Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-Titrated Automated Intermittent Boluses vs Continuous Infusion for Postoperative Analgesia
NCT05091905Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Mar 2022
- Primary completion
- Mar 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in acute postoperative pain, sponsored by University of California, San Diego. Started Mar 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT05091905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091905.